Literature DB >> 9516903

Lymphocyte dynamics: caution in interpreting BAL numbers.

R Pabst1, T Tschernig.   

Abstract

In various allergic and inflammatory lung diseases the number and subset composition of lymphocytes in the bronchoalveolar lavage (BAL) fluid are taken as indicators of the state of the disease. The number of lymphocytes in the BAL fluid depends on three main parameters: (1) entry into the bronchoalveolar space from the different compartments of the lung, (2) persistence in the bronchoalveolar space which is modified by the rate of local proliferation and apoptosis, and (3) exit into the draining bronchial lymph node via the lymphatic system. In healthy individuals lymphocytes in the BAL fluid seem to be a stable pool: each day there is hardly any entry, local cell division or cell death and few lymphocytes emigrate from this compartment. In contrast, during inflammatory, toxic and allergic reactions all parameters can increase rapidly with more lymphocytes entering, proliferating and/or undergoing apoptosis locally. Very little is known about factors such as cytokines and chemokines which may regulate these parameters. When interpreting data on lymphocyte numbers in patients, lymphocyte dynamics in the bronchoalveolar space have to be considered, and in the future it may be possible to manipulate these lymphocyte fluxes for therapeutic purposes.

Entities:  

Mesh:

Year:  1997        PMID: 9516903      PMCID: PMC1758469          DOI: 10.1136/thx.52.12.1078

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection.

Authors:  G Semenzato
Journal:  Eur Respir J       Date:  1991-01       Impact factor: 16.671

2.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.

Authors:  M Chilosi; F Menestrina; P Capelli; L Montagna; M Lestani; G Pizzolo; A Cipriani; C Agostini; L Trentin; R Zambello
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

3.  Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid.

Authors:  T Sandström; L Bjermer; R Rylander
Journal:  Eur Respir J       Date:  1992-09       Impact factor: 16.671

4.  Lymphocytes migrate from the bronchoalveolar space to regional bronchial lymph nodes.

Authors:  R Pabst; R M Binns
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

5.  Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease.

Authors:  C Agostini; R Zambello; R Sancetta; A Cerutti; A Milani; C Tassinari; M Facco; A Cipriani; L Trentin; G Semenzato
Journal:  Am J Respir Crit Care Med       Date:  1996-04       Impact factor: 21.405

  5 in total
  6 in total

1.  A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.

Authors:  Elizabeth Fireman; Yehuda Lerman; Moshe Stark; Asher Pardo; Yehuda Schwarz; Michael V Van Dyke; Jill Elliot; Briana Barkes; Lee Newman; Lisa Maier
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

2.  Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.

Authors:  A Klemm; T Tschernig; N Krug; R Pabst
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.

Authors:  H Stridh; A Planck; D Gigliotti; A Eklund; J Grunewald
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 4.  New ideas on the pathophysiology and treatment of lung disease.

Authors:  D F Rogers; G J Laurent
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 5.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

6.  What is the clinical relevance of different lung compartments?

Authors:  Thomas Tschernig; Reinhard Pabst
Journal:  BMC Pulm Med       Date:  2009-08-11       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.